Sparteine

CHEMBL1908847 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
234.4 g/mol
LogP
2.5
Phase
4

Sparteine is a quinolizidine alkaloid derived from lupine plants with antiarrhythmic properties, acting as a class Ia sodium channel blocker to slow cardiac conduction, and also possessing oxytocic properties used historically to stimulate uterine contractions during labor. Its antiarrhythmic activity is similar to quinidine and procainamide, prolonging the action potential and effective refractory period. It has largely been replaced by more selective and better-characterized antiarrhythmic agents.

分子量

234.3800 g/mol

LogP

2.50

TPSA

6.50 Ų

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@@H]34)[C@H]2C1

InChI

InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m0/s1

Molecular Formula

C15H26N2

HBD / HBA

- / 2

回転可能結合数

0

重原子数

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Sparteine is a quinolizidine alkaloid derived from lupine plants with antiarrhythmic properties, acting as a class Ia sodium channel blocker to slow cardiac conduction, and also possessing oxytocic properties used historically to stimulate uterine contractions during labor. Its antiarrhythmic activity is similar to quinidine and procainamide, prolonging the action potential and effective refractory period. It has largely been replaced by more selective and better-characterized antiarrhythmic agents.

Yes, Sparteine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908847. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 644020. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.